PUBLISHER: Persistence Market Research | PRODUCT CODE: 1450763
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1450763
Blood Screening Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
Persistence Market Research has conducted a thorough analysis of the Blood Screening Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Blood Screening Market spanning from 2023 to 2030.
The Blood Screening market is anticipated to grow at a compound annual growth rate (CAGR) of 8.5%, resulting in a rise from US$2.22 billion in 2023 to US$3.94 billion by the conclusion of 2030.
Key Insights:
- Blood Screening Market Size (2023E): US$2.22 Bn
- Projected Market Value (2030F): US$3.94 Bn
- Global Market Growth Rate (CAGR 2023 to 2030): 8.5%
- Historical Market Growth Rate (CAGR 2018 to 2022):7.2%
- Revenue Share of Top Four Countries (2022E):45%
Blood Screening Market - Report Scope
Blood screening involves the systematic analysis of blood samples to detect various pathological conditions, infections, and diseases. It is essential for monitoring diseases, ensuring blood transfusion safety, and promoting preventive healthcare. This diagnostic method is vital for timely identification of blood-borne illnesses like HIV and hepatitis, aiding in public health measures and medical intervention.
The global blood screening market is expanding due to factors such as technological advancements in screening methods, increasing prevalence of infectious diseases, and growing demand for blood transfusions. Stringent regulatory frameworks focusing on blood safety, recognition of early disease detection's importance, and improving healthcare infrastructure in emerging economies further drive market growth. Advancements in screening techniques and the emphasis on personalized medicine also contribute to industry development.
Market Growth Drivers
The global blood screening industry is advancing rapidly through the integration of cutting-edge screening technologies. Innovations such as nucleic acid testing (NAT) and automation have enhanced diagnostic precision and efficiency, shortening detection windows for infections like hepatitis and HIV. Robotics and automation streamline workflows, reduce errors, and increase output, particularly in large-scale diagnostic settings. Emerging technologies like next-generation sequencing (NGS) enable simultaneous analysis of multiple pathogens, improving diagnostic efficacy. Point-of-care testing (POCT) devices offer decentralized screening options, enhancing accessibility, particularly in resource-limited or remote areas. Despite technological advancements, regulatory hurdles pose significant challenges. Stringent compliance mandates necessitate substantial time and resources, delaying the commercialization of innovative screening solutions. Adapting to evolving regulatory standards incurs additional operational costs, highlighting the ongoing complexity of the regulatory environment in the blood screening market.
Market Restraints
The ongoing need for pandemic preparedness presents a significant challenge for the global blood screening market. Emergent infectious diseases like Zika, Ebola, and COVID-19 underscore the vulnerability of blood supplies to new pathogens. Heightened vigilance is required in screening protocols to quickly detect and address emerging threats of transfusion-transmissible infections. Developing and validating specific screening tests for novel diseases adds complexity and time to the screening process, emphasizing the necessity for continual adaptation and preparedness in the face of evolving infectious disease risks.
Table of Contents
1. Executive Summary
- 1.1. Global Blood Screening Market Snapshot, 2023 and 2030
- 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
3. Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
4. Global Blood Screening Market Outlook: Region
5. North America Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6. Europe Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7. East Asia Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8. South Asia & Oceania Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9. Latin America Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10. Middle East & Africa Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
11. Competition Landscape
12. Appendix
